Back to GetFilings.com



 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


 

FORM 10-Q

 

ý

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

 

 

 

For the quarterly period ended March 31, 2003

 

 

 

o

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

 

 

 

For the transition period from                         to                         

 

 

 

 

 

Commission File Number:  0-21134

 

Paligent Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

 

04-2893483

(State or other jurisdiction of
incorporation or organization)

 

(I.R.S.  Employer
Identification No.)

 

 

 

369 Lexington Avenue, New York, New York

 

10017

(Address of principal executive offices)

 

(zip code)

 

(212) 453-3111

(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

YES  ý   NO  o

 

The number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

 

Class

 

Outstanding as of May 9, 2003

 

 

 

Common Stock, $0.01 par value

 

32,490,948

 

 



 

PALIGENT INC.

 

INDEX

 

PART I.

FINANCIAL INFORMATION

 

 

 

 

 

 

Item 1.

Financial Statements

 

 

 

 

 

 

 

Condensed Consolidated Balance Sheets
March 31, 2003 (unaudited) and December 31, 2002

 

 

 

 

Condensed Consolidated Statements of Operations (unaudited)
Three months ended March 31, 2003 and 2002

 

 

 

 

Condensed Consolidated Statements of Cash Flows (unaudited)
Three months ended March 31, 2003 and 2002

 

 

 

 

 

 

Notes to Condensed Consolidated Financial Statements (unaudited)

 

 

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

 

Item 3.

Quantitative and Qualitative Disclosure About Market Risk

 

 

 

 

 

Item 4.

Controls and Procedures

 

 

 

 

 

 

PART II.

OTHER INFORMATION

 

 

 

 

 

 

Item 6.

Exhibits and Reports on Form 8-K

 

 

 

 

 

 

SIGNATURES

 

 

 

 

 

 

CERTIFICATION

 

 

 

 

 

 

Exhibit 99.1 – Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

2



 

PALIGENT INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

 

 

 

March 31, 2003

 

December 31, 2002

 

 

 

(unaudited)

 

 

 

ASSETS

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

23,243

 

$

153,046

 

Prepaid expenses and other current assets

 

26,083

 

94

 

Total current assets

 

49,326

 

153,140

 

 

 

 

 

 

 

Property and equipment, net

 

67,137

 

75,789

 

Security deposits

 

77,582

 

77,582

 

Other assets

 

32,687

 

33,669

 

Total assets

 

$

226,732

 

$

340,180

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

148,553

 

$

95,061

 

Due to related party

 

30,000

 

 

Accrued compensation

 

6,410

 

10,037

 

Accrued professional services

 

60,000

 

75,000

 

Current portion of capital lease obligations

 

19,834

 

20,383

 

Total current liabilities

 

264,797

 

200,481

 

 

 

 

 

 

 

Deferred rent

 

30,818

 

32,342

 

Security deposits

 

20,000

 

20,000

 

Capital lease obligations

 

14,905

 

20,545

 

 

 

 

 

 

 

Stockholders’ equity (deficit):

 

 

 

 

 

Common stock, $.01 par value; 75,000,000 shares authorized; 32,490,948 shares issued and outstanding at March 31, 2003 and December 31, 2002

 

324,910

 

324,910

 

Additional paid-in capital

 

154,634,974

 

154,634,974

 

Accumulated deficit

 

(155,063,672

)

(154,893,072

)

Total stockholders’ equity (deficit)

 

(103,788

)

66,812

 

Total liabilities and stockholders’ equity (deficit)

 

$

226,732

 

$

340,180

 

 

The accompanying notes are an integral part of the condensed consolidated financial statements.

 

3



 

PALIGENT INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited)

 

 

 

Three months ended March 31,

 

 

 

2003

 

2002

 

Revenue:

 

 

 

 

 

Interest income

 

$

113

 

$

3,811

 

 

 

 

 

 

 

Costs and expenses:

 

 

 

 

 

General and administrative

 

170,713

 

272,975

 

 

 

 

 

 

 

Net loss

 

$

(170,600

)

$

(269,164

)

 

 

 

 

 

 

Basic and diluted net loss per common share

 

$

(0.01

)

$

(0.01

)

 

 

 

 

 

 

Weighted average number of common shares outstanding - basic and diluted

 

32,490,948

 

32,490,948

 

 

The accompanying notes are an integral part of the condensed consolidated financial statements.

 

4